Debt-to-equity of Bolt Biotherapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bolt Biotherapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Bolt Biotherapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 86%, a 101% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Bolt Biotherapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 86% +43% +101% 30 Sep 2025
Q2 2025 72% +33% +82% 30 Jun 2025
Q1 2025 60% +23% +61% 31 Mar 2025
Q4 2024 49% +14% +39% 31 Dec 2024
Q3 2024 43% +9.6% +29% 30 Sep 2024
Q2 2024 40% +7.8% +25% 30 Jun 2024
Q1 2024 37% +7.7% +26% 31 Mar 2024
Q4 2023 35% +7.7% +28% 31 Dec 2023
Q3 2023 33% +8.1% +32% 30 Sep 2023
Q2 2023 32% +8.7% +38% 30 Jun 2023
Q1 2023 30% +8.4% +40% 31 Mar 2023
Q4 2022 28% +11% +65% 31 Dec 2022
Q3 2022 25% +2.2% +9.7% 30 Sep 2022
Q2 2022 23% 30 Jun 2022
Q1 2022 21% 31 Mar 2022
Q4 2021 17% 31 Dec 2021
Q3 2021 23% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.